Gamma globulin > 10 cc inj
Products billed under this code include Gamastan.
Payment limit per 10 CC, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Gamastan.
Payment limit per 10 CC, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Gamastan | Grifols USA, LLC | 13533-0335-04 | 1 | $118.153 |
| Gamastan | Grifols USA, LLC | 13533-0335-12 | 1 | $118.153 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $118.153 | −$44.366 | 10 CC | Gamma globulin > 10 cc inj | v1, posted September 17, 2026 |
| 3Q26 | $162.519 | +$2.233 | 10 CC | Gamma globulin > 10 cc inj | v1, posted September 15, 2026 |
| 2Q26 | $160.286 | +$55.766 | 10 CC | Gamma globulin > 10 cc inj | v1, posted September 15, 2026 |
| 1Q26 | $104.52 | −$65.956 | 10 CC | Gamma globulin > 10 cc inj | v1, posted September 15, 2026 |
| 4Q25 | $170.476 | +$3.414 | 10 CC | Gamma globulin > 10 cc inj | v1, posted September 8, 2026 |
| 3Q25 | $167.062 | −$321.791 | 10 CC | Gamma globulin > 10 cc inj | v1, posted March 10, 2026 |
| 2Q25 | $488.853 | −$5.311 | 10 CC | Gamma globulin > 10 cc inj | v1, posted March 10, 2026 |
| 1Q25 | $494.164 | −$4.358 | 10 CC | Gamma globulin > 10 cc inj | v1, posted December 19, 2025 |
| 4Q24 | $498.522 | −$2.189 | 10 CC | Gamma globulin > 10 cc inj | v1, posted June 11, 2025 |
| 3Q24 | $500.711 | +$10.096 | 10 CC | Gamma globulin > 10 cc inj | v1, posted June 11, 2025 |
| 2Q24 | $490.615 | −$16.643 | 10 CC | Gamma globulin > 10 cc inj | v1, posted March 11, 2025 |
| 1Q24 | $507.258 | +$19.602 | 10 CC | Gamma globulin > 10 cc inj | v1, posted December 19, 2024 |
| 4Q23 | $487.656 | +$3.008 | 10 CC | Gamma globulin > 10 cc inj | v1, posted October 10, 2024 |
| 3Q23 | $484.648 | +$1.453 | 10 CC | Gamma globulin > 10 cc inj | v1, posted June 5, 2024 |
| 2Q23 | $483.195 | +$4.499 | 10 CC | Gamma globulin > 10 cc inj | v1, posted February 23, 2024 |
| 1Q23 | $478.696 | +$11.135 | 10 CC | Gamma globulin > 10 cc inj | v1, posted December 6, 2023 |
| 4Q22 | $467.561 | +$5.922 | 10 CC | Gamma globulin > 10 cc inj | v1, posted June 22, 2023 |
| 3Q22 | $461.639 | −$2.632 | 10 CC | Gamma globulin > 10 cc inj | v1, posted June 9, 2023 |
| 2Q22 | $464.271 | +$10.077 | 10 CC | Gamma globulin > 10 cc inj | v1, posted December 14, 2022 |
| 1Q22 | $454.194 | +$12.887 | 10 CC | Gamma globulin > 10 cc inj | v1, posted June 8, 2022 |
| 4Q21 | $441.307 | +$7.514 | 10 CC | Gamma globulin > 10 cc inj | v1, posted June 2, 2022 |
| 3Q21 | $433.793 | +$2.036 | 10 CC | Gamma globulin > 10 cc inj | v1, posted June 2, 2022 |
| 2Q21 | $431.757 | −$1.20 | 10 CC | Gamma globulin > 10 cc inj | v1, posted March 1, 2022 |
| 1Q21 | $432.957 | – | 10 CC | Gamma globulin > 10 cc inj | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.